Skip to content

Effect of fasting blood plasma level on COVID-19 patients

Effect of fasting blood plasma level on COVID-19 patients:A single center retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050864
Enrollment
Unknown
Registered
2021-09-05
Start date
2020-07-01
Completion date
Unknown
Last updated
2021-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

increased fasting blood glucose group vs. normal fasting blood glucose group:Nil

Sponsors

Beijing Ditan Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Hospitalized patients with COVID-19 and type 2 diabetes mellitus were divided into increased fasting blood glucose group and normal fasting blood glucose group according to their level of admission. The age, sex and severity of illness at admission were matched between the two groups. The inclusion criteria were (1) aged >= 18 years; (2) Patients diagnosed with covid-19;(3) Previously diagnosed as type 2 diabetes; The fasting blood glucose on the next day of admission was less than 7mmol / L.

Exclusion criteria

Exclusion criteria: Pregnant women or cancer patients; Patients with severe diseases, such as acute heart failure, acute stroke, diabetic ketosis, decompensated liver and kidney failure, etc.

Design outcomes

Primary

MeasureTime frame
Nucleic acid positive duration;

Countries

China

Contacts

Public ContactYingying Zhao

Beijing Ditan Hospital Affiliated to Capital Medical University

1265162707@qq.com+86 10-84322200

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026